Financial Products

A new multiyear pact between Envision Healthcare and BCBS of Arizona ends uncertainty, ensuring stable in-network access to critical medical services.

Europi Property Group and Incus Capital launch a major joint venture to expand Ecologis, aiming to invest €100M in sustainable logistics across Iberia.

Saving for a home is faster than in 2022, but a new report reveals a stark divide, with some facing a 30-year wait while others can buy in under two.

Nuveen is combining three tax-free income funds. For investors, this means lower fees and stable payouts, but also new state tax implications.

Blaire McClanahan's '40 Under 40' win signals a new generation of legal leadership and underscores the growing importance of estate planning in the Triad.

A €2.3M grant will help an Irish consortium develop advanced liquid cooling, tackling the immense energy demands of data centers and electric vehicles.

DPL hires Brad Mendenhall to expand its platform as RIAs increasingly embrace commission-free insurance for holistic, fiduciary-first financial planning.

Sweeping reforms pulled Florida's property insurance market from the brink of collapse. We decode the fixes, the capital influx, and the risks that still loom.

How RNR Tire Express turned a niche lease-to-own model into a recession-resistant franchise empire, reshaping automotive retail engagement along the way.

A fintech firm's new hire seems distant, but it signals a crucial shift in how capital flows into life-saving research and healthcare innovation.

Huntington Bank opens a South Euclid branch, blending community focus with an aggressive M&A strategy aiming to make it a top 10 U.S. bank.

Hedge fund Balyasny Asset Management builds a 1.72% stake in JTC plc, signaling high-stakes maneuvering in the £2.3 billion takeover saga.

Valmet’s oversubscribed €375M Schuldschein loan isn't just a funding win. It's a strategic pivot showcasing the rising power of private debt markets.

A $277M secondary offering sees MIAX shareholders cash in, but the company itself isn't taking any money. Here’s what that says about its financial power.

A regulatory filing uncovers a major bank's intricate derivatives strategy in a £2.3bn takeover, raising questions about market transparency.

Hedge fund Balyasny reveals a 1.26% economic stake in Just Group via derivatives, shining a light on the complex strategies at play in its takeover.

KB Home's sixth consecutive corporate responsibility award offers a surprising blueprint for the healthcare sector. Can a homebuilder's ESG strategy pay off for pharma?

Sarepta Therapeutics is trading higher interest costs for a longer financial runway. We decode the biotech's complex debt deal and what it signals.

The packaging giant pushed its debt wall to 2030 and stripped key covenants. We analyze the strategic brilliance and the high-stakes bargain for investors.

Grant Eason's promotion to Managing Director reveals more than a career move; it's a key to Capital Southwest's strategy in the heated private credit market.